Darrell Shane Lea - Nov 21, 2022 Form 4 Insider Report for Cellectar Biosciences, Inc. (CLRB)

Role
Chief Commercial Officer
Signature
/s/ Christina Blakley, Attorney in-fact for Darrell Shane Lea
Stock symbol
CLRB
Transactions as of
Nov 21, 2022
Transactions value $
$0
Form type
4
Date filed
12/15/2022, 04:00 PM
Next filing
Dec 12, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLRB Stock option (right to buy) Award $0 +100K $0.00 100K Nov 21, 2022 Common Stock 100K $1.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in three equal annual installments beginning on the first anniversary of the date of grant, subject to the Reporting Person's continuous employment by the Issuer on each vesting date.